Literature DB >> 27034117

Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats.

Hariom Kumar1, Bhupesh Sharma2.   

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder, commonly characterized by altered social behavior, communication, biochemistry and pathological conditions. One percent of the worldwide population suffers from autism and males suffer more than females. NMDA receptors have the important role in neurodevelopment, neuropsychiatric and neurodegenerative disorders. This study has been designed to investigate the role of memantine, a NMDA receptor modulator, in prenatal valproic acid-induced autism in rats. Animals with prenatal valproic acid have shown the reduction in social interaction (three-chamber social behavior apparatus), spontaneous alternation (Y-Maze), exploratory activity (Hole board test), intestinal motility, serotonin levels (both in prefrontal cortex and ileum) and prefrontal cortex mitochondrial complex activity (complex I, II, IV). Furthermore, prenatal valproic acid-treated animals have shown an increase in locomotion (actophotometer), anxiety (elevated plus maze), brain oxidative stress (thiobarbituric acid reactive species, glutathione, catalase), nitrosative stress (nitrite/nitrate), inflammation (both in brain and ileum myeloperoxidase activity), calcium and blood-brain barrier permeability. Treatment with memantine has significantly attenuated prenatal valproic acid-induced reduction in social interaction, spontaneous alteration, exploratory activity intestinal motility, serotonin levels and prefrontal cortex mitochondrial complex activity. Furthermore, memantine has also attenuated the prenatal valproic acid-induced increase in locomotion, anxiety, brain oxidative and nitrosative stress, inflammation, calcium and blood-brain barrier permeability. Thus, it may be concluded that prenatal valproic acid has induced autistic behavior, biochemistry and blood-brain barrier impairment in animals, which were significantly attenuated by memantine. NMDA receptor modulators like memantine should be explored further for the therapeutic benefits in autism.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autism; Blood-brain barrier permeability; Intestinal motility; Mitochondrial complex; NMDA receptor; Serotonin

Mesh:

Substances:

Year:  2016        PMID: 27034117     DOI: 10.1016/j.brainresbull.2016.03.013

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  9 in total

1.  Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders.

Authors:  Charllyany Sabino Custódio; Bruna Stefânia Ferreira Mello; Adriano José Maia Chaves Filho; Camila Nayane de Carvalho Lima; Rafaela Carneiro Cordeiro; Fábio Miyajima; Gislaine Z Réus; Silvânia Maria Mendes Vasconcelos; Tatiana Barichello; João Quevedo; Antônio Carlos de Oliveira; David Freitas de Lucena; Danielle S Macedo
Journal:  Mol Neurobiol       Date:  2017-05-23       Impact factor: 5.590

2.  Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function.

Authors:  Somayeh Mohammadi; Majid Asadi-Shekaari; Mohsen Basiri; Mahdieh Parvan; Mohammad Shabani; Masoumeh Nozari
Journal:  Psychopharmacology (Berl)       Date:  2019-10-08       Impact factor: 4.530

Review 3.  Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.

Authors:  Ning Cheng; Jong M Rho; Susan A Masino
Journal:  Front Mol Neurosci       Date:  2017-02-21       Impact factor: 5.639

Review 4.  Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models.

Authors:  Hsiao-Ying Kuo; Fu-Chin Liu
Journal:  Front Cell Neurosci       Date:  2018-11-20       Impact factor: 5.505

Review 5.  Looking for "fNIRS Signature" in Autism Spectrum: A Systematic Review Starting From Preschoolers.

Authors:  Eugenia Conti; Elena Scaffei; Chiara Bosetti; Viviana Marchi; Valeria Costanzo; Valerio Dell'Oste; Raffaele Mazziotti; Liliana Dell'Osso; Claudia Carmassi; Filippo Muratori; Laura Baroncelli; Sara Calderoni; Roberta Battini
Journal:  Front Neurosci       Date:  2022-03-02       Impact factor: 4.677

6.  Potential Cross Talk between Autism Risk Genes and Neurovascular Molecules: A Pilot Study on Impact of Blood Brain Barrier Integrity.

Authors:  Rekha Jagadapillai; Xiaolu Qiu; Kshama Ojha; Zhu Li; Ayman El-Baz; Shipu Zou; Evelyne Gozal; Gregory N Barnes
Journal:  Cells       Date:  2022-07-15       Impact factor: 7.666

7.  Under or Absent Reporting of Light Stimuli in Testing of Anxiety-Like Behaviors in Rodents: The Need for Standardization.

Authors:  Lorenz S Neuwirth; Michael T Verrengia; Zachary I Harikinish-Murrary; Jessica E Orens; Oscar E Lopez
Journal:  Front Mol Neurosci       Date:  2022-08-17       Impact factor: 6.261

Review 8.  Potential crosstalk between sonic hedgehog-WNT signaling and neurovascular molecules: Implications for blood-brain barrier integrity in autism spectrum disorder.

Authors:  Evelyne Gozal; Rekha Jagadapillai; Jun Cai; Gregory N Barnes
Journal:  J Neurochem       Date:  2021-08-06       Impact factor: 5.546

Review 9.  Pathophysiological Studies of Monoaminergic Neurotransmission Systems in Valproic Acid-Induced Model of Autism Spectrum Disorder.

Authors:  Hsiao-Ying Kuo; Fu-Chin Liu
Journal:  Biomedicines       Date:  2022-02-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.